SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-042544
Filing Date
2023-08-14
Accepted
2023-08-14 17:24:12
Documents
93
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q celu-20230630.htm   iXBRL 10-Q 4504419
2 EX-10.11 celu-ex10_11.htm EX-10.11 166393
3 EX-31.1 celu-ex31_1.htm EX-31.1 21384
4 EX-31.2 celu-ex31_2.htm EX-31.2 21372
5 EX-32.1 celu-ex32_1.htm EX-32.1 13820
6 EX-32.2 celu-ex32_2.htm EX-32.2 13525
7 GRAPHIC img141982078_0.jpg GRAPHIC 3255
  Complete submission text file 0000950170-23-042544.txt   19708669

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT celu-20230630_cal.xml EX-101.CAL 72589
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT celu-20230630.xsd EX-101.SCH 125566
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT celu-20230630_lab.xml EX-101.LAB 847663
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT celu-20230630_pre.xml EX-101.PRE 678160
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT celu-20230630_def.xml EX-101.DEF 532922
87 EXTRACTED XBRL INSTANCE DOCUMENT celu-20230630_htm.xml XML 4674905
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38914 | Film No.: 231172122
SIC: 2834 Pharmaceutical Preparations